We have recently found that the cyclized peptide SRSRY ([SRSRY]) inhibits in a dose-dependent manner directional migration of rat basophilic leukemia RBL-2H3/ETFR cells expressing high levels of constitutively activated FPR1. Here, FPR1 is linked to acute basophilic leukemia.